Global Custom Market Research Reports Provider Company

phone

Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review

  • Published Date: 29 Aug 2018
  • Number of Pages: 51
  • Category: SWOT Analysis
  • Country: United States of America
Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear. The companys Otiprio is the US FDA approved ciprofloxacin otic suspension indicated during tympanostomy tube placement surgery in pediatric patients. Its pipeline portfolio encompasses Otividex for the treatment of Menieres disease (Phase 3); OTO-313 for the treatment of tinnitus (Phase 1/2); OTO-5XX for the treatment of cisplatin-induced hearing loss (Phase 2), OTO-413 for the treatment of synaptopathy hearing loss; and OTO-6XX for the treatment of severe hearing loss. Otonomy is also investigating a preclinical program on sensorineural hearing loss including age-related hearing loss. It employs its proprietary formulation technology that uses a thermosensitive gel and drug microparticles for enabling single dose treatment by a physician. Otonomy is headquartered in San Diego, California, the US.

Otonomy Inc Key Recent Developments

Aug 08,2018: Otonomy reports second quarter 2018 financial results and provides corporate update
May 09,2018: Otonomy Reports First Quarter 2018 Financial Results and Provides Corporate Update
Mar 08,2018: Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Jan 09,2018: Otonomy Provides Corporate and Product Pipeline Update
Nov 27,2017: Otonomy Announces Plan to Focus Resources on Development Programs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData

3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Otonomy Inc - Key Facts 6
Otonomy Inc - Key Employees 7
Otonomy Inc - Key Employee Biographies 8
Otonomy Inc - Major Products and Services 10
Otonomy Inc - History 11
Otonomy Inc - Company Statement 12
Otonomy Inc - Locations And Subsidiaries 13
Head Office 13
Section 2 Company Analysis 14
Company Overview 14
Otonomy Inc - Business Description 15
R&D Overview 15
Otonomy Inc - Corporate Strategy 16
Otonomy Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
Otonomy Inc - Strengths 17
Otonomy Inc - Weaknesses 18
Otonomy Inc - Opportunities 19
Otonomy Inc - Threats 20
Otonomy Inc - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 Companys Lifesciences Financial Deals and Alliances 28
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Otonomy Inc, Recent Deals Summary 30
Section 5 Companys Recent Developments 31
Aug 08, 2018: Otonomy reports second quarter 2018 financial results and provides corporate update 31
May 09, 2018: Otonomy Reports First Quarter 2018 Financial Results and Provides Corporate Update 33
Mar 08, 2018: Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 34
Jan 09, 2018: Otonomy Provides Corporate and Product Pipeline Update 36
Nov 27, 2017: Otonomy Announces Plan to Focus Resources on Development Programs 38
Nov 08, 2017: Otonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update 39
Sep 13, 2017: Otonomy Provides Business and Financial Update 40
Aug 03, 2017: Otonomy Reports Second Quarter 2017 Financial Results and Provides Corporate Update 41
May 04, 2017: Otonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update 43
Mar 02, 2017: Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 45
Section 6 Appendix 47
Methodology 47
Ratio Definitions 47
About GlobalData 51
Contact Us 51
Disclaimer 51

List Of Tables


Otonomy Inc, Key Facts 6
Otonomy Inc, Key Employees 7
Otonomy Inc, Key Employee Biographies 8
Otonomy Inc, Major Products and Services 10
Otonomy Inc, History 11
Otonomy Inc, Key Competitors 21
Otonomy Inc, Ratios based on current share price 22
Otonomy Inc, Annual Ratios 23
Otonomy Inc, Annual Ratios (Cont...1) 24
Otonomy Inc, Interim Ratios 26
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Otonomy Inc, Recent Deals Summary 30
Currency Codes 47
Capital Market Ratios 47
Equity Ratios 48
Profitability Ratios 48
Cost Ratios 49
Liquidity Ratios 49
Leverage Ratios 50
Efficiency Ratios 50

List Of Figures


Otonomy Inc, Performance Chart (2013 - 2017) 25
Otonomy Inc, Ratio Charts 27
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Otonomy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Leclanche SA (LECN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports